Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms  Joseph D. Schmoker, MD, Kenneth J. McPartland, MD, Erika K. Fellinger, MD, Jon Boyum, MD, Lucy Trombley, MS, Frank P. Ittleman, MD, Christopher Terrien, MD, Andrew Stanley, MD, Alan Howard, MS  The Journal of Thoracic and Cardiovascular Surgery  Volume 133, Issue 1, Pages 155-161 (January 2007) DOI: 10.1016/j.jtcvs.2006.07.036 Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Endogenous activity of MMP-2 in the atherosclerotic thoracic aortic wall relative to aortic size (R2 = 0.30, P = .004). MMP-2, Matrix metalloproteinase-2. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 155-161DOI: (10.1016/j.jtcvs.2006.07.036) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions